Cited by 29Hormonal and reproductive studiesBone health and osteoporosis researchMenopause: Health Impacts and Treatments

Effects of Low-Dose Testosterone Undecanoate Treatment on Bone Mineral Density and Bone Turnover Markers in Elderly Male Osteoporosis with Low Serum Testosterone

Open access
Wang, Yan-Jiao, Zhan, Jun-Kun, Huang, Wu, Wang, Yi, Liu, Yuan, Wang, Sha, Tan, Pan, Tang, Zhi-Yong +1 more·2013·International Journal of Endocrinology

Abstract

This prospective 2-year, single-center, randomized, placebo-controlled, open-label clinical trial was performed to evaluate the efficacy of low-dose testosterone undecanoate (TU) treatment on bone mineral density (BMD) and biochemical markers of bone turnover in elderly male osteoporosis with low serum testosterone. A total of 186 elderly male osteoporosis patients with low serum testosterone were randomized into three groups: low-dose TU (20 mg, per day), standard-dose TU (40 mg, per day), and placebo group with a 24-month followup. Since the 6th month in standard-dose TU group or since the 12th month followup in low-dose TU group and throughout the study, lumbar spine and femoral neck BMD and serum levels of free testosterone, estradiol, and bone alkaline phosphatase significantly increased. There were no significant differences between groups of low-dose TU and standard dose TU in the percentage of changes of these data since the 18th month followup and throughout the study. No side effects on prostate glands including prostate specific antigen were found. In conclusion, low-dose TU (20 mg, per day) may be a cost effective and safe protocol for treating elderly male osteoporosis with low serum testosterone.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2013/570413

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In trials, patients with low testosterone have demonstrated statistically significant improvements in erectile function, sex drive, anemia, bone mineral density, lean body mass, and depressive symptoms.

    “In trials, patients with low testosterone have demonstrated statistically significant improvements in erectile function, 24 sex drive, 24 anemia, 25 bone mineral density, 26 lean body mass, 27 and depressive symptoms. 24”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [5]Committee on Assessing the Need for Clinical Trials of Testosterone Replacement Therapy Liverman CT Blazer DG Executive summary Testosterone and Aging: Clinical Research Directions 2004 Washington, DC, USA The National Academic Press 1 10

Cited by

Sorted by citations

Authors
Wang, Y.-J., Zhan, J.-K., Huang, W., Wang, Y., Liu, Y., Wang, S., Tan, P., Tang, Z.-Y., & Liu, Y.-S.
Affiliations
  • Geriatric Department of the Second Xiang-Ya Hospital, Institute of Aging and Geriatric Research, Central South University, No. 139 Middle Renmin Road, Changsha, Hunan 410011, China
  • Central South University (CN)
Corresponding author
Liu, You-Shuo
Venue
International Journal of Endocrinology
Publisher
Wiley
Published
2013
Volume
2013
Pages
1-6
ISSN
  • 1687-8337 (ISSN-L)
  • 1687-8345
OpenAlex
W2134033218
Cited by
29
References
26
Citations by year
2025: 3 · 2024: 2 · 2023: 1 · 2022: 4 · 2021: 2 · 2020: 1 · 2019: 1 · 2018: 4 · 2017: 3 · 2016: 2 · 2015: 3 · 2014: 3
FWCI
2.10
Type
journal article
Language
en
Open access
Locations
  • International Journal of Endocrinology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • National Natural Science Foundation of China (30871191, 201302008, 09JJ3037)
  • Ministry of Health of China (30871191, 201302008, 09JJ3037)
  • Hunan Provincial Natural Science Foundation (30871191, 201302008, 09JJ3037)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
Keywords
testosterone undecanoate, male osteoporosis, older men, androgen deficiency, bone mineral density, bone turnover markers, alkaline phosphatase, estradiol, free testosterone, lumbar spine, femoral neck, prostate-specific antigen

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review